ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,472Medicare Part D Prescriptions Filled, Including Refills

Rank: 32 out of 1844

$1.04M Total Retail Price of All Prescriptions

Rank: 38 out of 1844

641 Patients Receiving at Least One Drug in Part D
45%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 641 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

42% of this provider’s 641 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 8,925 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 1,817 646 S3 1 2
OMEPRAZOLE 801 328 2 5
LISINOPRIL 682 419 3 4
METFORMIN HCL 458 182 4 8
PRAVASTATIN SODIUM 436 229 5 10
LEVOTHYROXINE SODIUM 409 208 6 1
FUROSEMIDE 403 232 7 7
CITALOPRAM HBR 319 146 8 19
GLIMEPIRIDE 295 169 9 35
TRAMADOL HCL 287 70 10 18
SIMVASTATIN 269 196 11 3
TRAZODONE HCL 246 79 12 43
ZOLPIDEM TARTRATE 242 128 13 23
HYDROCHLOROTHIAZIDE 223 108 14 9
CYCLOBENZAPRINE HCL 223 67 R 14 53
METOPROLOL TARTRATE 206 140 16 11
NEXIUM 205 109 17 31
FLUOXETINE HCL 201 117 18 41
AMLODIPINE BESYLATE 193 156 19 6
CYMBALTA 183 18 20 36
AMOXICILLIN 168 88 21 101
AZITHROMYCIN 168 71 21 37
SERTRALINE HCL 159 64 23 21
WARFARIN SODIUM 155 72 24 13
GABAPENTIN 154 58 25 15
SPIRIVA 147 75 26 57
ROPINIROLE HCL 143 70 27 76
AMITRIPTYLINE HCL 141 52 R 28 72
PROAIR HFA 133 34 29 45
PAROXETINE HCL 128 74 30 68
PROMETHAZINE HCL 128 28 R 30 88
ATORVASTATIN CALCIUM 127 66 32 12
CRESTOR 118 52 33 30
LANTUS 113 69 34 42
COMBIVENT 113 54 34 131
KLOR-CON M20 112 57 36 54
TRIAMTERENE-HYDROCHLOROTHIAZID 111 76 37 161
MELOXICAM 111 66 37 28
POLYETHYLENE GLYCOL 3350 106 41 39 39
ACTOS 106 74 39 130
VENTOLIN HFA 104 58 41 145
OXYCODONE HCL-ACETAMINOPHEN 104 54 S2 41 83
IBUPROFEN 101 15 43 89
TAMSULOSIN HCL 101 60 43 27
METOPROLOL SUCCINATE 100 57 45 14
ETODOLAC 97 26 46 178
ATENOLOL 96 62 47 17
PREDNISONE 91 49 48 40
HUMALOG 91 50 48 114
CLONIDINE HCL 91 58 48 64
DOXYCYCLINE HYCLATE 89 56 51 90
LEVOFLOXACIN 86 43 52 78
ESTRADIOL 85 55 R 53 181
CLOPIDOGREL 84 48 54 34
INSULIN SYRINGE 84 32 54 111
PANTOPRAZOLE SODIUM 84 33 54 32
LYRICA 83 15 57 92
CIPROFLOXACIN HCL 82 45 58 62
ALLOPURINOL 80 74 59 29
CEPHALEXIN 79 48 60 56
ZETIA 78 35 61 81
ABILIFY 78 0 61 150
VERAPAMIL ER 75 54 63 98
FLUCONAZOLE 74 11 64 187
CARVEDILOL 74 54 64 22
CLOTRIMAZOLE-BETAMETHASONE 73 25 66 202
VENLAFAXINE HCL ER 72 38 67 93
LISINOPRIL-HYDROCHLOROTHIAZIDE 71 45 68 20
ADVAIR DISKUS 70 45 69 51
MIRTAZAPINE 68 40 70 49
HYDROXYZINE HCL 67 32 R 71 164
PLAVIX 65 46 72 61
SULFAMETHOXAZOLE-TRIMETHOPRIM 64 35 73 73
PIOGLITAZONE HCL 57 35 R 74 327
DONEPEZIL HCL 57 31 74 26
BUPROPION HCL SR 57 21 74 196
GEMFIBROZIL 57 30 74 108
FLUTICASONE PROPIONATE 57 21 74 50
DICYCLOMINE HCL 55 14 79 197
NABUMETONE 54 22 80 158
LOSARTAN POTASSIUM 53 43 81 24
LANTUS SOLOSTAR 53 16 81 97
TIZANIDINE HCL 53 0 81 141
FAMOTIDINE 52 0 84 63
RANITIDINE HCL 52 11 84 38
PROCHLORPERAZINE MALEATE 52 24 84 441
FENTANYL 51 42 S2 87 66
HALOBETASOL PROPIONATE 50 32 88 455
JANUMET 50 42 88 211
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 21, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.